Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
AbbVie
ABBV
|
+$3.06B |
| 2 |
Pfizer
PFE
|
+$1.93B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.67B |
| 4 |
Morgan Stanley
MS
|
+$1.59B |
| 5 |
Constellation Energy
CEG
|
+$1.25B |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$2.84B |
| 2 |
Exelon
EXC
|
+$2.5B |
| 3 |
Gilead Sciences
GILD
|
+$1.81B |
| 4 |
Union Pacific
UNP
|
+$1.68B |
| 5 |
Microsoft
MSFT
|
+$1.33B |
Sector Composition
| 1 | Technology | 23.02% |
| 2 | Financials | 14.78% |
| 3 | Healthcare | 14.09% |
| 4 | Communication Services | 11.78% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Genmab
GMAB
$17.1B
| $145M | 0.03% |
3,952,446
+283,031
| +8% | +$10.4M |
|
277
Novanta
NOVT
$4.12B
| $145M | 0.03% |
1,015,687
+4,500
| +0.4% | +$640K |
|
278
Evertec
EVTC
$2.14B
| $142M | 0.03% |
3,472,822
+8,381
| +0.2% | +$343K |
|
279
Enpro
NPO
$4.64B
| $140M | 0.03% |
1,432,727
+556,751
| +64% | +$54.4M |
|
280
Xcel Energy
XEL
$43.4B
| $139M | 0.03% |
1,930,010
-1,057,480
| -35% | -$76.3M |
|
281
TELUS International
TIXT
$1.25B
| $137M | 0.03% |
5,536,117
+699,567
| +14% | +$17.3M |
|
282
Global Payments
GPN
$20.7B
| $134M | 0.03% |
975,820
+2,138
| +0.2% | +$293K |
|
283
Enphase Energy
ENPH
$4.92B
| $133M | 0.03% |
659,197
-424,756
| -39% | -$85.7M |
|
284
Trupanion
TRUP
$1.87B
| $133M | 0.03% |
1,487,447
| – | – |
|
285
BWX Technologies
BWXT
$15.4B
| $131M | 0.03% |
2,438,755
-1,629,012
| -40% | -$87.7M |
|
286
Huazhu Hotels Group
HTHT
$11.4B
| $131M | 0.03% |
3,980,217
+61,482
| +2% | +$2.03M |
|
287
Corpay
CPAY
$21.7B
| $131M | 0.03% |
525,276
+1,011
| +0.2% | +$252K |
|
288
STMicroelectronics
STM
$23.1B
| $128M | 0.03% |
2,857,566
+83,859
| +3% | +$3.76M |
|
289
Elastic
ESTC
$9.3B
| $127M | 0.03% |
1,424,310
-1,192,873
| -46% | -$106M |
|
290
Lowe's Companies
LOW
$152B
| $125M | 0.03% |
615,787
-18,515
| -3% | -$3.74M |
|
291
Regal Rexnord
RRX
$9.22B
| $124M | 0.03% |
+836,742
| New | +$124M |
|
292
Ryan Specialty Holdings
RYAN
$6.61B
| $122M | 0.03% |
3,139,432
-2,968
| -0.1% | -$115K |
|
293
HDFC Bank
HDB
$179B
| $120M | 0.03% |
1,963,798
+267,246
| +16% | +$16.4M |
|
294
Pacific Biosciences
PACB
$351M
| $116M | 0.03% |
12,781,855
+675,537
| +6% | +$6.15M |
|
295
LiveRamp
RAMP
$1.73B
| $115M | 0.03% |
3,065,422
+244,405
| +9% | +$9.14M |
|
296
Goosehead Insurance
GSHD
$2.05B
| $114M | 0.03% |
1,456,513
-300,410
| -17% | -$23.6M |
|
297
TPG
TPG
$9.05B
| $114M | 0.03% |
+3,790,593
| New | +$114M |
|
298
Arcosa
ACA
$4.67B
| $113M | 0.03% |
1,967,470
| – | – |
|
299
Vir Biotechnology
VIR
$695M
| $111M | 0.03% |
4,329,516
-1,176,050
| -21% | -$30.2M |
|
300
Incyte
INCY
$16.2B
| $111M | 0.03% |
1,397,265
-2,661,792
| -66% | -$211M |
|